The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...

At a dinner with reporters in San Francisco, OpenAI CEO Sam Altman spilled details on the company's ambitions beyond ChatGPT.

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.

OpenAI's CEO is reportedly raising funds for a brain implant startup that would directly compete with Elon Musk's Neuralink.

Sam Altman plans to support a brain computer interface startup to rival Neuralink, as OpenAI expands its AI and technology ...

Elon Musk threatened to sue Apple, claiming its App Store favored OpenAI’s ChatGPT. OpenAI may back a start-up, Merge Labs, ...

OpenAI CEO Sam Altman is reportedly working to launch a new brain-to-computer interface company, Merge Labs, with early ...

Sam Altman sees OpenAI eventually investing "trillions" in the infrastructure necessary to power artificial intelligence, but ...

The U.S. economy is in a strange place. Inflation is stubborn at 2.7%, job growth numbers have been revised down, trade barriers are up, investment sentiment is dropping in some quarters like the ...